1. Home
  2. EVOK vs CREV Comparison

EVOK vs CREV Comparison

Compare EVOK & CREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • CREV
  • Stock Information
  • Founded
  • EVOK 2007
  • CREV 2007
  • Country
  • EVOK United States
  • CREV Ireland
  • Employees
  • EVOK N/A
  • CREV 449
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • CREV
  • Sector
  • EVOK Health Care
  • CREV
  • Exchange
  • EVOK Nasdaq
  • CREV Nasdaq
  • Market Cap
  • EVOK 6.5M
  • CREV 7.5M
  • IPO Year
  • EVOK 2013
  • CREV N/A
  • Fundamental
  • Price
  • EVOK $4.47
  • CREV $3.66
  • Analyst Decision
  • EVOK
  • CREV Strong Buy
  • Analyst Count
  • EVOK 0
  • CREV 1
  • Target Price
  • EVOK N/A
  • CREV $39.00
  • AVG Volume (30 Days)
  • EVOK 29.5K
  • CREV 1.6M
  • Earning Date
  • EVOK 03-13-2025
  • CREV 01-01-0001
  • Dividend Yield
  • EVOK N/A
  • CREV N/A
  • EPS Growth
  • EVOK N/A
  • CREV N/A
  • EPS
  • EVOK N/A
  • CREV N/A
  • Revenue
  • EVOK $8,617,036.00
  • CREV $39,261,077.00
  • Revenue This Year
  • EVOK $97.35
  • CREV $40.76
  • Revenue Next Year
  • EVOK $99.52
  • CREV $86.18
  • P/E Ratio
  • EVOK N/A
  • CREV N/A
  • Revenue Growth
  • EVOK 100.35
  • CREV 41.52
  • 52 Week Low
  • EVOK $3.54
  • CREV $2.00
  • 52 Week High
  • EVOK $12.32
  • CREV $22.49
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 47.52
  • CREV 40.99
  • Support Level
  • EVOK $4.30
  • CREV $4.72
  • Resistance Level
  • EVOK $4.58
  • CREV $5.90
  • Average True Range (ATR)
  • EVOK 0.26
  • CREV 0.67
  • MACD
  • EVOK -0.00
  • CREV -0.36
  • Stochastic Oscillator
  • EVOK 48.22
  • CREV 0.00

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About CREV Carbon Revolution Public Limited

Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.

Share on Social Networks: